Cancer News

New Class of Drugs in Early Trials Offers Hope for Breast Cancer - Wall Street Journal


AFP

New Class of Drugs in Early Trials Offers Hope for Breast Cancer
Wall Street Journal
A new class of drugs under development at several pharmaceutical companies showed promise in early studies against two types of especially tough-to-treat breast cancer. The compounds, known as PARP inhibitors, work by obstructing the ability of cells ...
Progress but no cure reported at major cancer conference USA Today
New breast cancer drugs block cell repair enzyme Reuters
Sanofi's Breast Cancer Bet Forbes
Bloomberg - AFP
all 63 news articles

Monitor Online | News | Museveni, Nkurunziza, join cancer battle

The unit, which is expected to cost over Shs600 million, aims at bringing treatment closer to the homes of cancer patients, and maintain the highest standard of care. President Museveni contributed Shs16 million and promised to ...

Riding in Place to Fight Breast Cancer : TreeHugger

Photo from City Coach How would you react if you lost your mother to breast cancer? If you are Jonathan Cane, you'd organize a virtual-cross-country bicycle race in the storefront on one of Manhattan's busiest streets.

Roche Presents Several Abstracts for New Targeted Cancer Drugs at

Roche presented final efficacy results from a Phase II study of a new antibody-drug conjugate, T-DMI (trastuzumab plus DMI), that has shown treatment benefit in metastatic breast cancer patients whose cancer had progressed despite ...

Roche Presents Several Abstracts for New Targeted Cancer Drugs at

Roche presented several studies supporting new combination treatments with Herceptin in stomach cancer and in metastatic breast cancer and reported promising data on an investigational pharmacogenomics-guided melanoma treatment at the ...

Herceptin Slows Some Stomach Cancer - Wall Street Journal


Health Newstrack

Herceptin Slows Some Stomach Cancer
Wall Street Journal
By THOMAS GRYTA A new study shows that Roche Holding AG's breast-cancer drug Herceptin is also effective in a subtype of stomach cancers, marking the first new use for the blockbuster drug. The findings, disclosed at the annual meeting of the American ...
Breast cancer drug may help patients with stomach cancer USA Today
Roche's Herceptin Fights Stomach Cancer in Those With Gene Bloomberg
Herceptin improves stomach cancer survival: study Reuters
BusinessWeek - GenomeWeb Daily News
all 84 news articles

ASCO Awards Researchers Personalizing Cancer Treatment with

Clara Bloomfield, the William G. Pace III Endowed chair of cancer research at Ohio State University, received the 2009 David A. Karnofsky Memorial Award for her investigations into viable treatment options for older patients with acute ...

Haney, 'voice of NASA' reporter, dies of cancer - The Associated Press


KRQE

Haney, 'voice of NASA' reporter, dies of cancer
The Associated Press
ALAMOGORDO, NM (AP) — Paul Haney, who was known as the "voice of NASA's Mission Control" for his live televised reports during the early years of the space program, has died of cancer. He was 80. Haney died Thursday at a nursing home. ...
Man who was voice of NASA dies of cancer in NM KVIA
Haney remembered for his voice Alamogordo Daily News
all 81 news articles

OncoGenex CEO seeks prostate cancer drug partner - Reuters


OncoGenex CEO seeks prostate cancer drug partner
Reuters
By Deena Beasley ORLANDO, Florida (Reuters) - OncoGenex Pharmaceuticals Inc, having demonstrated that its experimental prostate cancer drug extends survival by nearly seven months, is now focused on finding a partner to develop the drug, the company's ...
OncoGenex Drug Helps Prostate Cancer Patients Live Longer in Small ... Xconomy
OncoGenex Prostate Drug Extends Survival TheStreet.com
OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides ... PR Newswire (press release)
PR Newswire (press release)
all 38 news articles

Immune therapies finally working against cancer - Democratic

At a cancer conference Sunday, researchers said one such vaccine kept a common form of lymphoma from worsening for more than a year. That's huge in this field, where progress is glacial and success with a new treatment is often measured ...
This information is not intended to replace the advice of a doctor. Cancer1News.com disclaims any liability for the decisions you make based on this information.